Home / Import refusals / AEK-7261265-6/13/1

AEK-7261265-6/13/1

Boehringer Ingelheim Pharmaceuticals, Inc. — FEI 1219205

Recent inspections

  • 1281125 (VAI Thu Sep 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1219707 (NAI Fri Sep 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1112627 (VAI Thu Dec 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1073537 (VAI Thu Dec 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1004536 (VAI Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-9187474-1/10001/1 (Tue Jan 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0076188-4/11/1 (Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-3409955-4/11/1A (Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-1982855-5/11/1 (Thu Nov 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-6671732-3/11/4 (Mon Jan 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
July 2, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75